Autologous Protein Solution (APS) is a new therapy for the treatment of Osteoarthritis. This therapy is formed from a patient’s blood and contains high concentrations of anti-inflammatory and anabolic proteins
Osteoarthritis (OA) is a progressive and degenerative disease, which may result in significant pain and decreased quality of life. Recent updates in our understanding of OA have demonstrated that it is a whole joint disease that has many similarities to an unhealed wound containing inflammatory cytokines. The nSTRIDE Autologous Protein Solution (APS) Kit is a medical device under development for the treatment of OA. The APS Kit processes a patient’s own blood at the point of care to contain high concentrations of anti-inflammatory cytokines and anabolic growth factors. This study assessed the safety and treatment effects of a single intra-articular injection of APS.
The nSTRIDE Autologous Protein Solution (APS) kit has been developed to process autologous blood to produce an output (herein referred to as APS) with high concentrations of anti-inflammatory cytokines and anabolic growth factors. APS has been shown to block the effects of inflammation in chondrocytes,6 macrophages,8 and cartilage
Dr Anshu Sachdev founder of Knee Klinik has treated over 10,000 Patients for knee & Joint pains. Dr.Anshu believes in holistic treatment methodology. Patients, in early stages, are treated through medication and physiotherapies.